İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2018

Nodular lymphocyte predominant Hodgkin’s lymphoma in dailypractice: A multicenter experience

HEMATOLOGICAL ONCOLOGY

YÖKSİS OpenAlex SJR Q2 JCR Q2 Atıf 5 Yüzdelik 59.1% FWCI 0.35
Yıl
2018
ISSN
0278-0232
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) is a rare subtype of Hodgkin's lymphoma. In this study, we aimed to investigate the clinical features and therapeutic outcomes of patients with NLPHL who were diagnosed at different institutes in Turkey. We retrospectively reviewed the records of the patients diagnosed with NLPHL. Adult patients who were diagnosed after 2005 with histological confirmation were selected for the study. Forty-three patients were included in the study. Median age of patients was 37.5 years (18-70) at the time of diagnosis. About 60.5% patients were diagnosed as stage I and II NLPHL, and remaining 39.5% had stage III and IV disease. Median follow-up was 46 months. During follow-up, none of the patients died. Seven patients relapsed or progressed after initial therapy at a median of 12 months. Five of 7 relapsed/refractory patients (71.4%) were salvaged with chemotherapy only (DHAP, ICE), and the remaining 2 (28.6%) were salvaged with chemoimmunotherapy. All of relapsed/refractory patients were able to achieve complete remission after salvage therapy. Lactate dehydrogenase levels were significantly higher in patients with progressive disease compared with nonprogressive disease. Our study showed an excellent outcome with all patients alive at last contact with a median follow up of 46 months despite a wide range of different therapeutic approaches. All relapsed and refractory patients were successfully salvaged despite a low frequency of patients received immunotherapy in conjunction with chemotherapy. Our results suggest that immunotherapy may be reserved for further relapses.

Konular

  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment

Birincil konu Lymphoma Diagnosis and Treatment

Yazarlar

  1. ALİ İHSAN GEMİCİ
  2. İSMET AYDOĞDU
  3. HATİCE TERZİ SİVAS CUMHURİYET ÜNİVERSİTESİ
  4. MEHMET ŞENCAN
  5. ALMA ASLAN
  6. ALİ HAKAN KAYA
  7. MEHMET SİNAN DAL
  8. OLGA MELTEM AKAY
  9. MEHMET HİLMİ DOĞU
  10. MEHMET ORHAN AYYILDIZ
  11. FAHRİ ŞAHİN
  12. GÜLSÜM AKGÜN ÇAĞLAYAN
  13. MEHMET YILMAZ
  14. ZAFER GÖKGÖZ
  15. YUSUF BİLEN
  16. CENGİZ DEMİR
  17. ÖMÜR GÖKMEN SEVİNDİK
  18. SERDAL KORKMAZ
  19. BÜLENT ESER
  20. FEVZİ ALTUNTAŞ ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ
  21. ALİ İRFAN EMRE TEKGÜNDÜZ MALTEPE ÜNİVERSİTESİ